The AICube Project

AICube wants to provide cutting edge alternatives to ease prevention behaviors and deliver predicting medicine solutions.

AICUBE was founded at the very end of 2018. Our mission is to enhance the level of secondary prevention of several non-communicable diseases such as Type II diabetes. There is indeed the possibility to perform early diagnosis on diseases that if detected on time can be managed or eventually reduced the related complications.

Secondary prevention can be implemented by measuring values of specific biomarkers on a daily or weekly basis to gain statistically significant data.

We have therefore patented and developed a device that collects a saliva sample in non-invasive mode by means of an "augmented" electric toothbrush. The saliva sample is then moved to a unit (Base) that measures the value of the reference biomarker.


DNA mapping to start prevention pathway


(Glucose first)

Collection of valuable biomarkers on a daily basis

Machine Learning

Proprietary Machine Learning Algorithm

Data Organising Collector Device

The AICube wants to suggest specific care treatments to improve life quality and reduce the cost of healthcare consequently. The AICube developed, designed, and patented DOC.D© (Data Organising Collector Device), the first device that collects different biomarkers thanks to a non-invasive daily routine.

These biomarkers are analyzed through a POP (Point of Prevention) analyzer featuring a disposable cartridge and a set of tests. The outcomes are processed through a Machine Learning algorithm in a Machine Learning server, “The Cube”, connected wirelessly. The Cube evaluates the data from each user, together with the dataset of the main parameters already included in the database and continuously updated.

AICUBE Partners: